Cargando…

Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool

DNA methylation represents a crucial mechanism of epigenetic regulation in hematologic malignancies. The methylation process is controlled by specific DNA methyl transferases and other regulators, which are often affected by genetic alterations. Global hypomethylation and hypermethylation of tumor s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalinkova, Lenka, Sevcikova, Aneta, Stevurkova, Viola, Fridrichova, Ivana, Ciernikova, Sona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820560/ https://www.ncbi.nlm.nih.gov/pubmed/36614080 http://dx.doi.org/10.3390/ijms24010633

Ejemplares similares

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
por: Sevcikova, Aneta, et al.
Publicado: (2023)

Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?
por: Fridrichova, Ivana, et al.
Publicado: (2022)

Tumor microbiome – an integral part of the tumor microenvironment
por: Ciernikova, Sona, et al.
Publicado: (2022)

The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
por: Sevcikova, Aneta, et al.
Publicado: (2022)

miR-205-5p Downregulation and ZEB1 Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer
por: Kalinkova, Lenka, et al.
Publicado: (2021)

Age and Geographical Distribution in Families with BRCA1/BRCA2 Mutations in the Slovak Republic
por: Ciernikova, Sona, et al.
Publicado: (2006)

The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
por: Ciernikova, Sona, et al.
Publicado: (2020)

Probiotic Survey in Cancer Patients Treated in the Outpatient Department in a Comprehensive Cancer Center
por: Ciernikova, Sona, et al.
Publicado: (2016)

Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
por: Ciernikova, Sona, et al.
Publicado: (2020)

Analysis of bacteria from intestinal tract of FAP patients for the presence of APC-like sequences
por: Holec, Vladimir, et al.
Publicado: (2012)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
por: Kalinkova, Lenka, et al.
Publicado: (2020)

Decreased methylation in the SNAI2 and ADAM23 genes associated with de-differentiation and haematogenous dissemination in breast cancers
por: Kalinkova, Lenka, et al.
Publicado: (2018)

Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development
por: Nikolaieva, Nataliia, et al.
Publicado: (2022)

miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer
por: Fridrichova, Ivana, et al.
Publicado: (2020)

Diagnostics and Prognostication of Myelodysplastic Syndromes
por: Zini, Gina
Publicado: (2017)

Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: a review
por: Chalova, Petra, et al.
Publicado: (2023)

Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families
por: Cierniková, S, et al.
Publicado: (2005)

Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes
por: Skalska-Bugala, Aleksandra, et al.
Publicado: (2022)

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
por: Shahjahani, Mohammad, et al.
Publicado: (2019)

Computational flow cytometry as a diagnostic tool in suspected‐myelodysplastic syndromes
por: Duetz, Carolien, et al.
Publicado: (2021)

DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Dexheimer, Geórgia Muccillo, et al.
Publicado: (2017)

Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity
por: Ciernikova, Sona, et al.
Publicado: (2021)

A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease‐free survival in low‐risk breast cancer patients
por: Zmetakova, Iveta, et al.
Publicado: (2019)

Prognostic Markers of Myelodysplastic Syndromes
por: Veryaskina, Yuliya Andreevna, et al.
Publicado: (2020)

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
por: Zhou, Jing‐Dong, et al.
Publicado: (2016)

DNA Methylation Is Correlated with Oxidative Stress in Myelodysplastic Syndrome—Relevance as Complementary Prognostic Biomarkers
por: Gonçalves, Ana Cristina, et al.
Publicado: (2021)

DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines
por: Urbanova, Maria, et al.
Publicado: (2022)

Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
por: He, Rong, et al.
Publicado: (2022)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
por: Shreve, Jacob, et al.
Publicado: (2020)

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis
por: Shou, Li-Hong, et al.
Publicado: (2017)

Down-regulation of traditional oncomiRs in plasma of breast cancer patients
por: Jurkovicova, Dana, et al.
Publicado: (2017)

Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Wong, Kah Keng, et al.
Publicado: (2021)

PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
por: Kontandreopoulou, Christina-Nefeli, et al.
Publicado: (2021)

Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes
por: Wan, Chengyao, et al.
Publicado: (2021)

Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment
por: Acha, Pamela, et al.
Publicado: (2022)

Letter to the Editor: Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma
por: Lam, Clara J. K., et al.
Publicado: (2015)

Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis
por: Tan, Xiangyu, et al.
Publicado: (2021)

Confirmation of HIV-like sequences in respiratory tract bacteria of Cambodian and Kenyan HIV-positive pediatric patients
por: Zajac, Vladimir, et al.
Publicado: (2011)

MicroRNAs in urine are not biomarkers of multiple myeloma
por: Sedlaříková, Lenka, et al.
Publicado: (2015)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_21d9cg4lbjhrrjdmk4jn6ijph5